Anticoagulants Flashcards

1
Q

Indications for anticoagulants

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Parenteral anticoagulants

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MOA of anticoagulants

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Three phases of coagulation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA of heparin

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Coagulation cascade

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Effects of thrombin

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Effects of antithrombin III

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Fractionated vs. unfractionated heparin

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HMWH has effect on _________ and factor X

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Low molecular weight heparins

A

Enoxaparin, dalteparin, tinzaparin

Administered SubQ with more predictable bioavailability
Longer half life and less need to monitor (unless child or obese)
Cleared by the kidneys and low risk of HIT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Indications and use for heparin and warfarin

A

Binds to endothelium and to plamsa proteins
Levels of heparin-binding proteins vary from person to person so there is an upredictable anticoagulant response
Monitoring and titration required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is heparin monitored, and what is the reversal?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Major adverse effect of heparin

A

Heparin-induced thrombocytopenia

Risk of clots because of antibody production that creates a prothrombotic environment, incidence is ~5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Low molecular weight heparin indications

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LMWH boxed warning

A

Spinal/epidural hematoma that could lead to paralysis

17
Q

Risks of Fondaparinux

A
18
Q

Indication for Argatroban

A

Treatment for heparin-induced thrombocytopenia

19
Q

Indication for Bivalirudin

A

IV infusion used as alternative to heparin in patients undergoing PCI

20
Q

Direct oral anticoagulants
Direct thrombin inhibitor/Factor Xa inhibitors

A
21
Q

Indications for oral anticoagulants

A
22
Q

MOA of warfarin

A
23
Q

Impact of genotype on S-warfarin clearance

A
24
Q

How long does warfarin typically take effect?

A

About 7 days

25
Q

How is warfarin managed, and what is the recommended INR level to be at?

A

INR

26
Q

Warfarin dosing and monitoring

A
27
Q

Factors that correlate with warfarin dose

A
28
Q

Warfarin adverse effects

A

Hypercoaguable state

29
Q

What is warfarin purple toe syndrome

A
30
Q

Reversal for warfarin

A
31
Q

How do the novel anticoagulants compare with warfarin

A
32
Q

Dabigatran clearance and absorption

A

80% renally cleared

Requires an acidic environment for absorption

33
Q

Consideration when taking Rivaroxaban?

A

Take it with food

34
Q

Boxed warning of the novel oral anticoagulants

A

Increased risk of thrombotic events/stroke in clinical trials

35
Q

Antidotes for novel oral anticoagulants

A